Quinoline derivatives, their preparation and pharmaceutical compositions comprising the same
申请人:Chi Dae-Yoon
公开号:US20050165006A1
公开(公告)日:2005-07-28
Novel quinoline derivatives were prepared and evaluated their pharmaceutical activities. The quinoline derivatives according to the present invention effectively bind serotonin transporter (SERT) which is called serotonin reuptake site. Serotonin is one of the neurotransmitter and the lack of its concentration in synapse cause the depression. The quinoline derivatives in this invention can interrupt reuptake of serotonin into presynaptic neuron resulting the increasement of concentration of serotonin in synapse as well as stimulating the signal through the binding with serotonin recepter. Thus, they can be used for the prevention and treatment of mental disorder, especially depression, caused by the deficiency of serotonin concentration in synapse.
通过本发明制备了新型喹啉衍生物,并评估了它们的药物活性。本发明的喹啉衍生物能够有效地结合血清素转运体(SERT),也称为血清素再摄取位点。血清素是一种神经递质,如果突触中缺乏其浓度,则会导致抑郁症。本发明中的喹啉衍生物可以中断血清素重新摄取到突触前神经元中,从而增加突触中血清素的浓度,并通过与血清素受体结合刺激信号。因此,它们可以用于预防和治疗由突触中血清素浓度不足引起的心理障碍,特别是抑郁症。